Genelux Corp. (GNLX)
NASDAQ · Healthcare
Genelux Corp. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 8,000 | 8,000 | 170,000 | 11.1M |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -33.2M | -31.7M | -24.2M | -3.0M |
| EBITDA | — | — | — | — |
| Net Income | -32.1M | -29.9M | -28.3M | -5.2M |
| Per Share Data | ||||
| EPS (diluted) | $-0.86 | $-0.95 | $-1.16 | $-0.57 |
| Shares Outstanding (dil.) | 37M | 31M | 24M | 9M |
Genelux Corp. Income Statement — FAQ
Genelux Corp. (GNLX) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GNLX's income statement history?
The chart and table above show Genelux Corp.'s income statement by year and by quarter, including the growth rate.